SamanTree Medical’s Histolog® Scanner Technology Featured in 13 Publications in Special BJU International Issue on Confocal Microscopy in Urology
SamanTree Medical, a global leader in surgical imaging innovation, today announced that Histolog Scanner confocal microscopy technology has been featured in 13 peer-reviewed clinical papers in a special issue of BJU International, one of the world’s leading journals in urology. The special edition focuses on a growing body of evidence of the role of confocal microscopy in urologic surgery.
SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.
SamanTree Medical, a leader in innovative surgical imaging solutions, today announced that it has received FDA 510(k) clearance of its Histolog® Scanner for imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture. This groundbreaking Swiss made device is designed to provide real-time, highresolution imaging of fresh tissue surfaces, offering surgeons and pathologists this information for excised tissue.
SamanTree Medical Raises $14M in Series B Financing Round to Support Global Expansion and Innovation in Surgical Treatment
SamanTree Medical, a leading medical technology company specializing in innovative solutions to improve the outcomes of surgery, today announced the closing of $14M as part of a Series B financing round. The new capital will be used to further develop and commercialize the Histolog® Scanner, expand its reach in Europe and the United States, and enhance its digital suite.
SamanTree Medical announces new clinical data at recent medical congresses in prostate, lung, breast, and brain cancer surgery
SamanTree Medical, a medical technology company specializing in innovative solutions to improve cancer treatment, is proud to announce new clinical data presented at recent medical congresses, where it showcased new results in four distinct medical indications. Separately, Professor Alex Mottrie, from Aalst, Belgium, performed a live bilateral nerve-sparing robot-assisted radical prostatectomy (RARP) with the Histolog to assess the margins of the resected prostate.
SamanTree Medical Appoints New Chief Executive Officer
SamanTree Medical, a medical technology company specializing in innovative solutions to improve cancer treatment, is thrilled to announce the appointment of Mr. Olivier Delporte as the new Chief Executive Officer, effectively immediately.
SamanTree Medical SA Announces Exciting Clinical Data Showing the Potential of the Histolog® Scanner to Be a Valid Alternative to Frozen Section Analysis in Prostate Cancer
SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data in prostate cancer, expanding the potential clinical utility of its proprietary medical imaging platform, the Histolog Scanner.
